To present current perspectives on assessment and management of Hypermobile Ehlers Danlos Syndrome and Hypermobility Spectrum Disorder, including discussion around the new classification system.
Learning Outcomes
  • Have an understanding of the pathophysiology, epidemiology, diagnostic criteria of children and adult with Hypermobile Ehlers Danlos Syndrome / Hypermobility Spectrum Disorder and associated co morbidities
  • Apply advanced clinical reasoning and skills in the assessment and management ofHypermobile Ehlers Danlos Syndrome / Hypermobility Spectrum Disorder and comorbidities for therapists in the context of the evolving evidence base and contemporary theory, with particular referral to the hand and wrist
  • Be able to select suitable outcome measures aligned to the WHO International Classification of Functioning Framework
Submit your questions and case studies before the course to guide the content and discussion forums!
  • 9:00am - Registration and welcome. Joint Hypermobility Syndrome/ Ehlers Danlos Syndrome – Hypermobility Type within the context of the hereditary disorders of connective tissue: epidemiology, aetiology, diagnosis and comorbidities.
  • 10:45 - Morning Tea
  • 11.00 - Assessment principles including outcome measures
  • 12:45 - Lunch
  • 13.15 - Principles of management
  • 14.45 - Afternoon Tea
  • 15.15 - Clinical scenarios and application for practice
  • 16.45 - Evaluation
  • 17:00 - Close


Lesson 1: Hypermobility? What's all the fuss about? Preview 3 min
  • Lesson 2: What is connective tissue? 5 min
  • Lesson 3: What is joint hypermobility and why look for it? 5 min
  • Lesson 4: Measuring Hypermobility 0 min